×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Cosmetic Surgery Market Size

ID: MRFR/MED/2279-HCR
80 Pages
Kinjoll Dey
October 2025

Cosmetic Surgery Market Research Report Information by Procedure Type {Invasive (Breast Augmentation, Liposuction, Nose Reshaping, Eyelid Surgery, Tummy Tuck, and Others) Non-invasive (Botox Injections, Soft Tissue Fillers, Chemical Peel, Laser Hair Removal, Microdermabrasion, Dermabrasion, and Others)}, by End User (Hospitals and Dermatology Clinics, Ambulatory Surgical Centers, and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cosmetic Surgery Market Infographic
Purchase Options

Cosmetic Surgery Size

Cosmetic Surgery Market Growth Projections and Opportunities

The cosmetic surgery Market is essentially affected by the unique changes in excellence norms. Cultural guidelines of magnificence are liable to change, and with an end goal to adjust to present day beliefs, people much of the time seek after surface level methods. The interest for specific corrective systems, for example, rhinoplasty or bosom expansion, encounters comparing variances in light of movements in excellence principles. Mechanical Progressions: The cosmetic surgery market is significantly influenced by technological advancements. The advances in laser technologies, 3-dimensional imaging, & minimally invasive surgical procedures all contribute to reduced delays, safer procedures, and progressed outcomes in surgical planning. Surgeons who accept these technologies may be able to appeal a wider range of clients who are looking for efficient, cutting-edge solutions. Virtual entertainment and VIP culture apply a critical and expansive effect on the cosmetic surgery industry, persuading various turns of events. Advice and powerhouses' actual appearances habitually influence people, in this way encouraging a preference for specific restorative upgrades. Restorative specialists may likewise use online entertainment stages as a promoting instrument to display their skill and tempt forthcoming clients. A segment change toward a maturing populace considerably affects the market for cosmetic surgery. The regular maturing process causes changes in facial elements and skin versatility as people progress in age. The attractiveness of cosmetic surgery, including facelifts and Botox infusions, develops among the people who want to save a young appearance. Upgraded Destigmatization and Acknowledgment: The cultural discernment and disgrace encompassing corrective medical procedure are dynamically lessening. As cultural mentalities change, more people will uncover their longing for corrective improvements as a way to defeat frailties or upgrade their confidence. This social change upgrades the reach and variety of clients that cosmetic surgery specialists draw in. The increased accessibility and affordability of cosmetic surgery procedures facilitate the market's expansion. Improvements in clinical the travel industry focuses and the accessibility of supporting choices add to the expanded openness of cosmetic surgery procedure to a more extensive range of people. The market's scope is expanded, and a diverse clientele is attracted by the democratization of cosmetic procedures. There is a developing pattern among buyers to favour modified and customized cosmetic surgery arrangements. Specialists who furnish modified methodology as per explicit stylish targets and individual inclinations are bound to engage an insightful customer base. The tendency towards customization rises above facial methodology and incorporates extra surface level mediations, for example, body molding. Injectables and laser medicines are instances of non-careful restorative systems that are encountering a flood in fame. These negligibly intrusive choices appeal to people who are fearful about ordinary surgeries because of their quick results and brief recuperation periods. The market elements show a change towards a more noteworthy tendency towards mediations that require less disturbance. The adherence to thorough security guidelines and administrative systems is critical on the lookout. Stakeholders in the healthcare business gain assurance and confidence when regulatory obligations are obeyed. Patients who are cautious and well-informed are more likely to pick surgeons and clinics that obey stringent safety protocols. The market elements are being impacted by the developing attention to the mental and close to home prosperity suggestions related with cosmetic surgery procedure. Various people see corrective methods as a method for working on their psychological and profound wellbeing notwithstanding their actual appearance. The administrations of specialists who take care of these all-encompassing worries could encounter a flood popular.

Cosmetic Surgery Market Size Graph
Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Leave a Comment

FAQs

What is the current valuation of the Cosmetic Surgery Market in 2025?

The Cosmetic Surgery Market is valued at approximately 60.22 USD Billion in 2024.

What is the projected market size for the Cosmetic Surgery Market by 2035?

The market is expected to reach a valuation of 135.51 USD Billion by 2035.

What is the expected CAGR for the Cosmetic Surgery Market during the forecast period 2025 - 2035?

The expected CAGR for the Cosmetic Surgery Market during the forecast period 2025 - 2035 is 7.65%.

Which companies are considered key players in the Cosmetic Surgery Market?

Key players in the market include Allergan, Galderma, Revance Therapeutics, Medytox, Ipsen, Hugel, Sientra, and Croma-Pharma.

What are the main segments of the Cosmetic Surgery Market?

The main segments of the market include Invasive Procedures, Non-Invasive Procedures, and End Users.

What was the market size for Invasive Procedures in 2024?

In 2024, the market size for Invasive Procedures was approximately 30.11 USD Billion.

Market Summary

As per MRFR analysis, the Cosmetic Surgery Market was estimated at 60.22 USD Billion in 2024. The Cosmetic Surgery industry is projected to grow from 64.83 USD Billion in 2025 to 135.51 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.65 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Cosmetic Surgery Market is experiencing a dynamic shift towards non-invasive procedures and personalized treatments.

  • The rise of non-invasive procedures is reshaping consumer preferences, particularly in North America. There is an increased focus on personalization, with patients seeking tailored solutions that cater to individual needs. Integration of technology in procedures is enhancing safety and efficacy, driving growth in the Asia-Pacific region. Growing acceptance of cosmetic surgery and advancements in surgical techniques are key drivers propelling the market forward.

Market Size & Forecast

2024 Market Size 60.22 (USD Billion)
2035 Market Size 135.51 (USD Billion)
CAGR (2025 - 2035) 7.65%
Largest Regional Market Share in 2024 North America

Major Players

<p>Allergan (US), Galderma (CH), Revance Therapeutics (US), Medytox (KR), Ipsen (FR), Hugel (KR), Medytox (KR), <a href="https://sientra.com/">Sientra</a> (US), Croma-Pharma (AT)</p>

Market Trends

The Cosmetic Surgery Market is currently experiencing a dynamic evolution, driven by a confluence of factors that shape consumer preferences and technological advancements. Increasing societal acceptance of aesthetic procedures appears to be a pivotal element, as individuals increasingly seek enhancements that align with personal ideals of beauty. This shift in perception is complemented by the proliferation of social media platforms, which serve as both a source of inspiration and a means of showcasing results. As a result, the market is witnessing a surge in demand for various procedures, ranging from minimally invasive techniques to more complex surgical interventions. Moreover, advancements in technology are likely to play a crucial role in the future trajectory of the Cosmetic Surgery Market. Innovations in surgical techniques and equipment may enhance safety and efficacy, thereby attracting a broader demographic. Additionally, the rise of telemedicine could facilitate consultations and follow-ups, making cosmetic procedures more accessible to a wider audience. As the market continues to evolve, it seems poised for sustained growth, driven by changing attitudes towards beauty and the continuous development of new technologies that enhance patient experiences and outcomes.

Rise of Non-Invasive Procedures

There is a noticeable trend towards non-invasive cosmetic procedures, which are perceived as safer and requiring less recovery time. Treatments such as injectables and laser therapies are gaining popularity, appealing to individuals who desire aesthetic improvements without the commitment of surgery.

Increased Focus on Personalization

The Cosmetic Surgery Market is witnessing a shift towards personalized treatment plans tailored to individual needs and preferences. This trend suggests that practitioners are increasingly considering the unique characteristics of each patient, leading to more satisfactory outcomes.

Integration of Technology in Procedures

The incorporation of advanced technology in cosmetic procedures is becoming more prevalent. Techniques such as 3D imaging and robotic-assisted surgeries may enhance precision and reduce complications, indicating a potential transformation in how procedures are performed.

Cosmetic Surgery Market Market Drivers

Influence of Social Media

The impact of social media on the Cosmetic Surgery Market cannot be overstated. Platforms such as Instagram and TikTok have become powerful tools for promoting cosmetic procedures, with influencers and celebrities showcasing their transformations. This visibility has led to increased awareness and interest in cosmetic surgery among younger demographics. Data indicates that a significant portion of individuals considering cosmetic procedures cite social media as a primary source of inspiration. The ability to share before-and-after photos and personal experiences has created a community that normalizes cosmetic enhancements. As social media continues to shape perceptions of beauty, the Cosmetic Surgery Market is likely to benefit from heightened demand driven by these platforms.

Rising Disposable Incomes

The Cosmetic Surgery Market is significantly influenced by rising disposable incomes across various demographics. As individuals experience increased financial freedom, they are more inclined to invest in personal aesthetics. This trend is particularly evident in emerging markets, where economic growth has led to a surge in the number of individuals seeking cosmetic enhancements. Market data suggests that higher income levels correlate with a greater willingness to spend on cosmetic procedures, thereby driving industry growth. This financial empowerment allows consumers to prioritize their appearance, further propelling the demand for cosmetic surgery. Consequently, the Cosmetic Surgery Market is poised for continued expansion as economic conditions improve and more individuals seek to enhance their physical appearance.

Advancements in Surgical Techniques

Innovations in surgical techniques are playing a crucial role in the growth of the Cosmetic Surgery Market. Minimally invasive procedures, such as endoscopic surgery and laser treatments, have gained popularity due to their reduced recovery times and lower risk of complications. Data indicates that the demand for such procedures has surged, with a significant percentage of patients opting for less invasive options. These advancements not only enhance patient safety but also improve aesthetic outcomes, making cosmetic surgery more appealing. As technology continues to evolve, the Cosmetic Surgery Market is likely to witness further developments that could redefine traditional surgical practices, attracting a wider audience and increasing overall market size.

Growing Acceptance of Cosmetic Surgery

The Cosmetic Surgery Market is experiencing a notable shift in societal attitudes towards cosmetic procedures. Increasingly, individuals view cosmetic surgery as a viable option for enhancing their appearance, leading to a rise in demand. According to recent data, the number of cosmetic procedures performed has increased significantly, with millions of procedures conducted annually. This growing acceptance is driven by factors such as celebrity endorsements and social media influence, which normalize cosmetic enhancements. As more people share their experiences online, the stigma surrounding cosmetic surgery diminishes, encouraging others to consider these options. This trend suggests that the Cosmetic Surgery Market will continue to expand as societal norms evolve, potentially leading to a broader demographic seeking these services.

Increased Focus on Mental Health and Well-being

The Cosmetic Surgery Market is increasingly intersecting with the growing emphasis on mental health and well-being. Many individuals seek cosmetic procedures not only for aesthetic reasons but also to boost self-esteem and confidence. Research indicates that individuals who undergo cosmetic surgery often report improved psychological well-being post-procedure. This trend highlights a shift in the perception of cosmetic surgery as a means of enhancing overall quality of life. As mental health awareness continues to rise, more individuals may consider cosmetic enhancements as a valid approach to achieving personal satisfaction. This evolving mindset suggests that the Cosmetic Surgery Market will continue to thrive as it aligns with broader societal trends focused on mental health and self-improvement.

Market Segment Insights

By Procedure Type: Invasive (Largest) vs. Non-Invasive (Fastest-Growing)

<p>The Cosmetic Surgery Market is distinctly divided between invasive and non-invasive procedures. Currently, invasive procedures hold a significant share of the market, with cosmetic surgeries such as liposuction, breast augmentation, and facelifts leading in popularity. This segment represents a substantial portion of overall cosmetic procedures, demonstrating consistent demand from consumers seeking significant physical enhancements. On the other hand, non-invasive procedures are experiencing a surge in popularity, positioning themselves as the fastest-growing category in the market. Treatments such as Botox and fillers, which offer minimal downtime and lower costs, are becoming increasingly preferred among younger demographics. The rising trend of self-improvement and beauty consciousness contributes to the rapid growth of non-invasive procedures, appealing to a broader audience.</p>

<p>Invasive (Dominant) vs. Non-Invasive (Emerging)</p>

<p>Invasive procedures are recognized as the dominant force in the Cosmetic Surgery Market, characterized by their complex nature and the commitment required from patients in terms of recovery and adjustments. Treatments such as full surgical enhancements provide significant and lasting results, justifying their continued popularity despite the associated risks. Conversely, non-invasive procedures are emerging as a formidable segment, thanks to technological advances that enhance safety and effectiveness. These include minimally invasive treatments that require little to no recovery time, attracting a diverse clientele seeking quick, effective beauty solutions without extensive commitment. This dynamic creates a competitive landscape where both segments vie for consumer attention in the evolving beauty culture.</p>

By Invasive Procedures: Breast Augmentation (Largest) vs. Liposuction (Fastest-Growing)

<p>In the Cosmetic Surgery Market, Breast Augmentation leads as the largest segment. This procedure caters to a wide demographic, driven by desires for aesthetics, body confidence, and personal empowerment. Liposuction, while not the largest, is rapidly gaining popularity due to its effectiveness in body contouring and the increasing awareness of minimally invasive techniques. Market trends indicate a growing acceptance of invasive procedures, influenced by social media, celebrity endorsements, and advancements in surgical technology. Patients are seeking tailored solutions, which include aesthetic enhancements and fat reduction techniques. As healthcare professionals continue to enhance their skills, both segments are likely to see a surge in demand, particularly among younger demographics keen on achieving idealised body images.</p>

<p>Breast Augmentation: Dominant vs. Eyelid Surgery: Emerging</p>

<p>Breast Augmentation stands as the dominant leader in the invasive procedures segment, appealing to a diverse audience seeking enhancements in breast volume and shape. This procedure is often perceived as synonymous with beauty and femininity, fostering its continued popularity. In contrast, Eyelid Surgery, although an emerging trend, is carving its niche primarily among older patients seeking rejuvenation. This procedure addresses concerns about aging, offering significant improvements in appearance and self-confidence. The rising interest in Eyelid Surgery is bolstered by its minimally invasive nature and quicker recovery times, appealing to those hesitant about extensive surgeries, thus driving its growth within the cosmetic surgery landscape.</p>

By Non-Invasive Procedures: Botox Injections (Largest) vs. Soft Tissue Fillers (Fastest-Growing)

<p>In the Cosmetic Surgery Market, the Non-Invasive Procedures segment showcases a diverse range of options catering to various cosmetic needs. Leading this segment, Botox Injections hold the largest market share, primarily due to their established reputation and widespread acceptance among consumers. Following closely, Soft Tissue Fillers continue to gain traction, appealing to a younger demographic focused on volume enhancement. Other notable procedures include Laser Hair Removal and Microdermabrasion, which contribute significantly to the overall dynamics of the market.</p>

<p>Botox Injections (Dominant) vs. Soft Tissue Fillers (Emerging)</p>

<p>Botox Injections serve as the dominant player in the Non-Invasive Procedures segment, renowned for their effectiveness in reducing wrinkles and fine lines. This procedure's stability in consumer preference stems from its quick application and minimal downtime, making it a staple in cosmetic enhancement. In contrast, Soft Tissue Fillers represent an emerging trend, particularly appealing to those seeking a youthful appearance without invasive surgery. Their versatility in facial contouring and restoration of volume has attracted a growing audience, positioning them as a strong contender in the evolving landscape of cosmetic procedures.</p>

By End User: Hospitals and Dermatology Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

<p>In the Cosmetic Surgery Market, the segment distribution reveals a dominance of Hospitals and Dermatology Clinics, accounting for the largest share. Their extensive infrastructure, specialized staff, and comprehensive services cater effectively to a wide range of cosmetic procedures, appealing to a broad demographic. Ambulatory Surgical Centers, although currently smaller, are gaining traction and are predicted to capture significant market share in the near future.</p>

<p>Hospitals and Dermatology Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)</p>

<p>Hospitals and Dermatology Clinics represent the dominant force in the Cosmetic Surgery Market, offering a comprehensive array of surgical and non-surgical procedures. These establishments benefit from advanced technology, skilled medical professionals, and established patient trust. In contrast, Ambulatory Surgical Centers are characterized by their efficiency and convenience, often providing cost-effective solutions with shorter recovery times. This segment is emerging rapidly as patients increasingly seek outpatient options. Both segments play crucial roles, but the growing demand for minimally invasive procedures and patient preferences towards convenience are propelling Ambulatory Surgical Centers to become significant competitors in the market.</p>

Get more detailed insights about Cosmetic Surgery Market Research Report- Global Forecast To 2035

Regional Insights

North America : Cosmetic Surgery Market Leader

North America remains the largest market for cosmetic surgery, accounting for approximately 40% of the global market share. The region's growth is driven by increasing consumer awareness, technological advancements, and a rising number of minimally invasive procedures. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in cosmetic products and procedures. The United States is the leading country in this sector, with a significant presence of key players such as Allergan and Revance Therapeutics. Canada also contributes to the market, focusing on innovative solutions and patient-centric services. The competitive landscape is characterized by a mix of established companies and emerging players, all striving to meet the growing demand for cosmetic enhancements.

Europe : Emerging Cosmetic Surgery Market Hub

Europe is witnessing a robust growth trajectory in the cosmetic surgery market, holding approximately 30% of the global share. Factors such as an aging population, increased disposable income, and a cultural shift towards aesthetic enhancement are driving demand. Regulatory frameworks across countries like Germany and France are evolving to support innovative procedures while ensuring patient safety, thus fostering market growth. Leading countries in this region include Germany, France, and the UK, where a high concentration of cosmetic clinics and skilled practitioners exists. The competitive landscape features major players like Galderma and Ipsen, alongside numerous local clinics. The market is characterized by a blend of traditional surgical procedures and advanced non-invasive techniques, catering to diverse consumer preferences.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is emerging as a significant player in the cosmetic surgery market, accounting for around 25% of the global share. The region's growth is fueled by rising disposable incomes, increasing awareness of aesthetic procedures, and a cultural acceptance of cosmetic enhancements. Countries like South Korea and Japan are at the forefront, with supportive regulations that encourage innovation and safety in cosmetic practices. South Korea is particularly notable for its advanced cosmetic surgery techniques and a high volume of procedures performed annually. The competitive landscape includes key players like Medytox and Hugel, which are expanding their offerings to meet the growing demand. The region is also witnessing an influx of international brands, enhancing the overall market dynamics and consumer choices.

Middle East and Africa : Emerging Market Potential

The Middle East and Africa region is gradually establishing itself in the cosmetic surgery market, holding about 5% of the global share. Factors such as increasing urbanization, rising disposable incomes, and a growing interest in aesthetic procedures are driving market growth. Countries like the UAE and South Africa are leading the way, with regulatory bodies working to ensure safety and quality in cosmetic practices. The UAE, particularly Dubai, is becoming a hub for cosmetic surgery, attracting both local and international patients. The competitive landscape features a mix of local clinics and international chains, providing a wide range of services. Key players are focusing on innovative techniques and personalized care to cater to the diverse needs of consumers in this region.

Key Players and Competitive Insights

The Cosmetic Surgery Market is currently characterized by a dynamic competitive landscape, driven by factors such as increasing consumer demand for aesthetic procedures, advancements in technology, and a growing emphasis on minimally invasive techniques. Key players like Allergan (US), Galderma (CH), and Revance Therapeutics (US) are strategically positioned to leverage these trends. Allergan (US), known for its flagship product Botox, continues to innovate with new formulations and applications, while Galderma (CH) focuses on expanding its portfolio of dermal fillers and skin care products. Revance Therapeutics (US) is making strides with its DaxibotulinumtoxinA injection, which promises longer-lasting results, thereby enhancing its competitive edge. Collectively, these strategies not only bolster individual company performance but also intensify competition within the market, as firms vie for consumer attention and market share.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. This approach is particularly evident in the operations of Medytox (KR) and Ipsen (FR), which have optimized their production processes to cater to regional markets more effectively. The Cosmetic Surgery Market appears moderately fragmented, with a mix of established players and emerging companies. The collective influence of these key players shapes market dynamics, as they engage in strategic partnerships and collaborations to enhance their product offerings and market reach.

In August 2025, Allergan (US) announced the launch of a new line of advanced dermal fillers designed to cater to the evolving preferences of consumers seeking natural-looking results. This strategic move is significant as it aligns with the growing trend towards less invasive procedures, positioning Allergan to capture a larger share of the market. The introduction of these fillers not only reinforces Allergan's commitment to innovation but also responds to consumer demands for products that enhance rather than alter appearance.

In September 2025, Galderma (CH) expanded its global footprint by entering into a strategic partnership with a leading aesthetic clinic chain in Asia. This collaboration aims to enhance the distribution of Galderma's products in the region, tapping into the burgeoning demand for cosmetic procedures. Such partnerships are crucial as they enable Galderma to leverage local expertise and consumer insights, thereby strengthening its market position and driving growth in a competitive landscape.

In October 2025, Revance Therapeutics (US) revealed plans to invest in AI-driven technologies to enhance patient experience and streamline operations. This initiative is indicative of a broader trend within the industry, where companies are increasingly integrating technology to improve service delivery and operational efficiency. By adopting AI solutions, Revance aims to differentiate itself in a crowded market, potentially setting new standards for patient engagement and satisfaction.

As of October 2025, the Cosmetic Surgery Market is witnessing a shift towards digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are becoming increasingly pivotal, as companies recognize the value of collaboration in navigating the complexities of the market. Looking ahead, competitive differentiation is likely to evolve, with a pronounced emphasis on innovation and technology rather than solely on price. This transition suggests that companies that prioritize research and development, alongside reliable supply chains, will be better positioned to thrive in an increasingly competitive environment.

Key Companies in the Cosmetic Surgery Market market include

Industry Developments

In February 2023, Candela Corporation introduced the new FDA-cleared Profound Matrix System. This multi-application solution, designed to repair, preserve, and restore skin at various stages of ageing, includes Sublime, Sublative RF, and all-new Matrix Pro applicators.

In June 2022, Cynosure introduced the PicoSure Pro device, the newest improvement to the PicoSure platform.

In March 2022, Health Canada has given its approval for Sientra breast implants. Through its local partner Kai Aesthetic, the company will offer breast implants in Canada. Sientra will uphold the highest quality, safety, and service standards for patients and plastic surgeons within the terms of the distribution agreement.

In September 2021, Galderma's Restylane portfolio grew and expanded. Restylane Eyesight was introduced as a focused treatment for under-eye shadows. The FDA authorized Restylane Defyne in February 2021 for the augmentation and treatment of mild to moderate chin retrusion in people over the age of 21.

The World Health Organization, also known as the WHO, is urged by US and Mexican authorities to declare an international health emergency due to a fungal epidemic linked to cosmetic procedures in Mexico. According to the Centers for Disease Control and Prevention, or CDC, meningitis claimed the lives of two patients who underwent surgeries under epidural anesthesia. Nearly 400 people are being watched in the United States and Mexico. In the Mexican town of Matamoros, two cosmetic surgery clinics have closed.

Authorities in the US and Mexico have advised people to get evaluated, even if they are asymptomatic, if they had procedures involving anesthesia with epidural performed at the River Side Surgical Center or Clinica K-3 since January.

A law that aims to control influencers' commercial activities and safeguard consumers from fraud and scams is being finalized in France. The National Assembly and the Senate have already approved the rule forbidding promoting cosmetic surgery and paying for sports betting subscriptions. Influencers must also disclose how much they have been compensated for advocating a product, whether photos have been edited, and whether artificial intelligence was used to create a person's face or body.

If someone violates the rules, they could spend a maximum of two years in jail, pay a fine of €300,000 ($320,000), and lose their right to use social media for business purposes. 

The legislators use examples like advertising alleged "drugs" for cancer or hair-loss-inducing cosmetics. The proposed law expands on existing French law, which strictly controls the promotion of goods like alcohol and tobacco. While the new bill might call for influencers to incorporate a display indicating which post is being sponsored, the existing law already requires advertising to be transparent.

Cosmetic Surgery Market Segmentation

Cosmetic Surgery Market Procedure Type Outlook

  • Invasive
    • Breast Augmentation
      • Breast Implants
        • Silicone Breast Implants
        • Saline Breast Implants
        • Smooth Breast Implants
        • Others
      • Fat Transfer Augmentation
    • Liposuction
      • Tumescent Liposuction
      • Ultrasound-Assisted Liposuction
      • Laser-Assisted Liposuction
  • Nose Reshaping
    • Turbinate Reduction
    • Septoplasty
    • Rhinosseptoplasty
    • Rhinoplasty
  • Eyelid Surgery
    • Upper Blepharoplasty
    • Lower Blepharoplasty
    • Bilateral Eyelid Surgery
    • Double Eyelid Surgery
    • Transconjunctival Eyelid Surgery
  • Tummy Tuck
    • Full Tummy Tuck
    • Mini Tummy Tuck
    • Extended Tummy Tuck
    • Others
  • Others
  • Non-Invasive
    • Botox Injections
      • Type A
      • Type B
    • Soft Tissue Fillers
  • Chemical Peel
    • Glycolic Chemical Peel
    • Lactic Peel
    • Retinol Peel
    • Others
  • Laser Hair Removal
  • Microdermabrasion
    • Diamond Microdermabrasion
    • Crystal Microdermabrasion
  • Dermabrasion
  • Others

Cosmetic Surgery Market End User Outlook

  • Hospitals and Dermatology Clinics
  • Ambulatory Surgical Centers
  • Others

Cosmetic Surgery Market Regional Outlook

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East
    • Africa
    • Latin America

Future Outlook

Cosmetic Surgery Market Future Outlook

<p>The Cosmetic Surgery Market is projected to grow at a 7.65% CAGR from 2024 to 2035, driven by technological advancements, increasing consumer awareness, and rising disposable incomes.</p>

New opportunities lie in:

  • <p>Expansion of telemedicine consultations for cosmetic procedures.</p><p>Development of personalized cosmetic surgery packages targeting millennials.</p><p>Investment in AI-driven surgical planning tools to enhance precision.</p>

<p>By 2035, the market is expected to solidify its position as a leader in aesthetic enhancements.</p>

Market Segmentation

Cosmetic Surgery Market End User Outlook

  • Hospitals and Dermatology Clinics
  • Ambulatory Surgical Centers
  • Others

Cosmetic Surgery Market Procedure Type Outlook

  • Invasive
  • Non-Invasive

Cosmetic Surgery Market Invasive Procedures Outlook

  • Breast Augmentation
  • Liposuction
  • Nose Reshaping
  • Eyelid Surgery
  • Tummy Tuck
  • Others

Cosmetic Surgery Market Non-Invasive Procedures Outlook

  • Botox Injections
  • Soft Tissue Fillers
  • Chemical Peel
  • Laser Hair Removal
  • Microdermabrasion
  • Dermabrasion
  • Others

Report Scope

MARKET SIZE 202460.22(USD Billion)
MARKET SIZE 202564.83(USD Billion)
MARKET SIZE 2035135.51(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.65% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesIntegration of advanced technologies enhances patient experience and expands service offerings in the Cosmetic Surgery Market.
Key Market DynamicsRising consumer demand for minimally invasive procedures drives innovation and competition in the cosmetic surgery market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Cosmetic Surgery Market in 2025?

The Cosmetic Surgery Market is valued at approximately 60.22 USD Billion in 2024.

What is the projected market size for the Cosmetic Surgery Market by 2035?

The market is expected to reach a valuation of 135.51 USD Billion by 2035.

What is the expected CAGR for the Cosmetic Surgery Market during the forecast period 2025 - 2035?

The expected CAGR for the Cosmetic Surgery Market during the forecast period 2025 - 2035 is 7.65%.

Which companies are considered key players in the Cosmetic Surgery Market?

Key players in the market include Allergan, Galderma, Revance Therapeutics, Medytox, Ipsen, Hugel, Sientra, and Croma-Pharma.

What are the main segments of the Cosmetic Surgery Market?

The main segments of the market include Invasive Procedures, Non-Invasive Procedures, and End Users.

What was the market size for Invasive Procedures in 2024?

In 2024, the market size for Invasive Procedures was approximately 30.11 USD Billion.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    3. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3 SECTION III: QUALITATIVE ANALYSIS
    4. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
    6. Healthcare, BY Procedure Type (USD Billion)
      1. Invasive
      2. Non-Invasive
    7. Healthcare, BY Invasive Procedures (USD Billion)
      1. Breast Augmentation
      2. Liposuction
      3. Nose Reshaping
      4. Eyelid Surgery
      5. Tummy Tuck
      6. Others
    8. Healthcare, BY Non-Invasive Procedures (USD Billion)
      1. Botox Injections
      2. Soft Tissue Fillers
      3. Chemical Peel
      4. Laser Hair Removal
      5. Microdermabrasion
      6. Dermabrasion
      7. Others
    9. Healthcare, BY End User (USD Billion)
      1. Hospitals and Dermatology Clinics
      2. Ambulatory Surgical Centers
      3. Others
    10. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
    11. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    12. Company Profiles
      1. Allergan (US)
      2. Galderma (CH)
      3. Revance Therapeutics (US)
      4. Medytox (KR)
      5. Ipsen (FR)
      6. Hugel (KR)
      7. Medytox (KR)
      8. Sientra (US)
      9. Croma-Pharma (AT)
    13. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    14. MARKET SYNOPSIS
    15. NORTH AMERICA MARKET ANALYSIS
    16. US MARKET ANALYSIS BY PROCEDURE TYPE
    17. US MARKET ANALYSIS BY INVASIVE PROCEDURES
    18. US MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    19. US MARKET ANALYSIS BY END USER
    20. CANADA MARKET ANALYSIS BY PROCEDURE TYPE
    21. CANADA MARKET ANALYSIS BY INVASIVE PROCEDURES
    22. CANADA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    23. CANADA MARKET ANALYSIS BY END USER
    24. EUROPE MARKET ANALYSIS
    25. GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
    26. GERMANY MARKET ANALYSIS BY INVASIVE PROCEDURES
    27. GERMANY MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    28. GERMANY MARKET ANALYSIS BY END USER
    29. UK MARKET ANALYSIS BY PROCEDURE TYPE
    30. UK MARKET ANALYSIS BY INVASIVE PROCEDURES
    31. UK MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    32. UK MARKET ANALYSIS BY END USER
    33. FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
    34. FRANCE MARKET ANALYSIS BY INVASIVE PROCEDURES
    35. FRANCE MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    36. FRANCE MARKET ANALYSIS BY END USER
    37. RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
    38. RUSSIA MARKET ANALYSIS BY INVASIVE PROCEDURES
    39. RUSSIA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    40. RUSSIA MARKET ANALYSIS BY END USER
    41. ITALY MARKET ANALYSIS BY PROCEDURE TYPE
    42. ITALY MARKET ANALYSIS BY INVASIVE PROCEDURES
    43. ITALY MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    44. ITALY MARKET ANALYSIS BY END USER
    45. SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
    46. SPAIN MARKET ANALYSIS BY INVASIVE PROCEDURES
    47. SPAIN MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    48. SPAIN MARKET ANALYSIS BY END USER
    49. REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
    50. REST OF EUROPE MARKET ANALYSIS BY INVASIVE PROCEDURES
    51. REST OF EUROPE MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    52. REST OF EUROPE MARKET ANALYSIS BY END USER
    53. APAC MARKET ANALYSIS
    54. CHINA MARKET ANALYSIS BY PROCEDURE TYPE
    55. CHINA MARKET ANALYSIS BY INVASIVE PROCEDURES
    56. CHINA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    57. CHINA MARKET ANALYSIS BY END USER
    58. INDIA MARKET ANALYSIS BY PROCEDURE TYPE
    59. INDIA MARKET ANALYSIS BY INVASIVE PROCEDURES
    60. INDIA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    61. INDIA MARKET ANALYSIS BY END USER
    62. JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
    63. JAPAN MARKET ANALYSIS BY INVASIVE PROCEDURES
    64. JAPAN MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    65. JAPAN MARKET ANALYSIS BY END USER
    66. SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
    67. SOUTH KOREA MARKET ANALYSIS BY INVASIVE PROCEDURES
    68. SOUTH KOREA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    69. SOUTH KOREA MARKET ANALYSIS BY END USER
    70. MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
    71. MALAYSIA MARKET ANALYSIS BY INVASIVE PROCEDURES
    72. MALAYSIA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    73. MALAYSIA MARKET ANALYSIS BY END USER
    74. THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
    75. THAILAND MARKET ANALYSIS BY INVASIVE PROCEDURES
    76. THAILAND MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    77. THAILAND MARKET ANALYSIS BY END USER
    78. INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
    79. INDONESIA MARKET ANALYSIS BY INVASIVE PROCEDURES
    80. INDONESIA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    81. INDONESIA MARKET ANALYSIS BY END USER
    82. REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
    83. REST OF APAC MARKET ANALYSIS BY INVASIVE PROCEDURES
    84. REST OF APAC MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    85. REST OF APAC MARKET ANALYSIS BY END USER
    86. SOUTH AMERICA MARKET ANALYSIS
    87. BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
    88. BRAZIL MARKET ANALYSIS BY INVASIVE PROCEDURES
    89. BRAZIL MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    90. BRAZIL MARKET ANALYSIS BY END USER
    91. MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
    92. MEXICO MARKET ANALYSIS BY INVASIVE PROCEDURES
    93. MEXICO MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    94. MEXICO MARKET ANALYSIS BY END USER
    95. ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
    96. ARGENTINA MARKET ANALYSIS BY INVASIVE PROCEDURES
    97. ARGENTINA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    98. ARGENTINA MARKET ANALYSIS BY END USER
    99. REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
    100. REST OF SOUTH AMERICA MARKET ANALYSIS BY INVASIVE PROCEDURES
    101. REST OF SOUTH AMERICA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    102. REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    103. MEA MARKET ANALYSIS
    104. GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
    105. GCC COUNTRIES MARKET ANALYSIS BY INVASIVE PROCEDURES
    106. GCC COUNTRIES MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    107. GCC COUNTRIES MARKET ANALYSIS BY END USER
    108. SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
    109. SOUTH AFRICA MARKET ANALYSIS BY INVASIVE PROCEDURES
    110. SOUTH AFRICA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    111. SOUTH AFRICA MARKET ANALYSIS BY END USER
    112. REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
    113. REST OF MEA MARKET ANALYSIS BY INVASIVE PROCEDURES
    114. REST OF MEA MARKET ANALYSIS BY NON-INVASIVE PROCEDURES
    115. REST OF MEA MARKET ANALYSIS BY END USER
    116. KEY BUYING CRITERIA OF HEALTHCARE
    117. RESEARCH PROCESS OF MRFR
    118. DRO ANALYSIS OF HEALTHCARE
    119. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    120. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    121. SUPPLY / VALUE CHAIN: HEALTHCARE
    122. HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
    123. HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
    124. HEALTHCARE, BY INVASIVE PROCEDURES, 2024 (% SHARE)
    125. HEALTHCARE, BY INVASIVE PROCEDURES, 2024 TO 2035 (USD Billion)
    126. HEALTHCARE, BY NON-INVASIVE PROCEDURES, 2024 (% SHARE)
    127. HEALTHCARE, BY NON-INVASIVE PROCEDURES, 2024 TO 2035 (USD Billion)
    128. HEALTHCARE, BY END USER, 2024 (% SHARE)
    129. HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    130. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    131. LIST OF ASSUMPTIONS
    132. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    133. US MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    134. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    135. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    136. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    137. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    138. France MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    139. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    140. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    141. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    142. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    143. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    144. China MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    145. India MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    146. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    147. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    148. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    149. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    150. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    151. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    152. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    153. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    154. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    155. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    156. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    157. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    158. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    159. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    160. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY PROCEDURE TYPE, 2025-2035 (USD Billion)
      2. BY INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      3. BY NON-INVASIVE PROCEDURES, 2025-2035 (USD Billion)
      4. BY END USER, 2025-2035 (USD Billion)
    161. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    162. ACQUISITION/PARTNERSHIP

Cosmetic Surgery Market Segmentation

Cosmetic Surgery Procedure Type Outlook (USD Billion, 2019-2030)

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Cosmetic Surgery End User Outlook (USD Billion, 2019-2030)

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Cosmetic Surgery Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)

North America Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

North America Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

US Outlook (USD Billion, 2019-2030)

US Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

US Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Canada Outlook (USD Billion, 2019-2030)

Canada Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Canada Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Europe Outlook (USD Billion, 2019-2030)

Europe Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Europe Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Germany Outlook (USD Billion, 2019-2030)

Germany Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Germany Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

France Outlook (USD Billion, 2019-2030)

France Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

France Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Italy Outlook (USD Billion, 2019-2030)

Italy Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Italy Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Spain Outlook (USD Billion, 2019-2030)

Spain Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Spain Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Rest of Europe Outlook (USD Billion, 2019-2030)

Rest of Europe Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Rest of Europe Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Asia-Pacific Outlook (USD Billion, 2019-2030)

Asia-Pacific Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Asia-Pacific Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

China Outlook (USD Billion, 2019-2030)

China Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

China Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Japan Outlook (USD Billion, 2019-2030)

Japan Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Japan Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

India Outlook (USD Billion, 2019-2030)

India Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

India Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

South Korea Outlook (USD Billion, 2019-2030)

South Korea Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

South Korea Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Australia Outlook (USD Billion, 2019-2030)

Australia Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Australia Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

Rest of Asia-Pacific Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Rest of Asia-Pacific Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Rest of the World Outlook (USD Billion, 2019-2030)

Rest of the World Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Rest of the World Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Middle East Outlook (USD Billion, 2019-2030)

Middle East Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

US Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Africa Outlook (USD Billion, 2019-2030)

Africa Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Africa Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Latin America Outlook (USD Billion, 2019-2030)

Latin America Cosmetic Surgery by Procedure Type

Invasive

Breast Augmentation

Breast Implants

Silicone Breast Implants

Saline Breast Implants

Smooth Breast Implants

Others

Fat Transfer Augmentation

Liposuction

Tumescent Liposuction

Ultrasound-Assisted Liposuction

Laser-Assisted Liposuction

Nose Reshaping

Turbinate Reduction

Septoplasty

Rhinosseptoplasty

Rhinoplasty

Eyelid Surgery

Upper Blepharoplasty

Lower Blepharoplasty

Bilateral Eyelid Surgery

Double Eyelid Surgery

Transconjunctival Eyelid Surgery

Tummy Tuck

Full Tummy Tuck

Mini Tummy Tuck

Extended Tummy Tuck

Others

Others

Non-Invasive

Botox Injections

Type A

Type B

Soft Tissue Fillers

Chemical Peel

Glycolic Chemical Peel

Lactic Peel

Retinol Peel

Others

Laser Hair Removal

Microdermabrasion

Diamond Microdermabrasion

Crystal Microdermabrasion

Dermabrasion

Others

Latin America Cosmetic Surgery by End User

Hospitals and Dermatology Clinics

Ambulatory Surgical Centers

Others

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Customer Strories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne

Founder

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions